Polish brief pain inventory for pain assessment and monitoring of pain treatment in patients with cancer

Journal of Palliative Medicine

Volumn 13, Issue 6, 2010, Pages 663-668

  Leppert, Wojciech ^a   Majkowicz, Mikolaj ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROCODEINE; OPIATE; TRAMADOL;

ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; DRUG DOSE TITRATION; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MALE; PAIN ASSESSMENT; POLAND; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE; DEVICES; MIDDLE AGED; NEOPLASM; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMETRY; QUESTIONNAIRE; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; POLAND; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 77954447265     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0326     Document Type: Article

References (15)

1. Daut RL, Cleeland CS, Flanery RC: The development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
2. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singap 1994;23: 129-138.
3. Leppert W, Luczak J: The role of tramadol in cancer pain treatment-A review. Support Care Cancer 2005;13:5-17. (Pubitemid 40193060)
4. Gravenstein JS, Smith GM, Sphire RD, Isaacs JP, Beecher HK: Dihydrocodeine. N Engl J Med 1956;254:877-885.
5. Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A, on behalf of the EORTC Quality of Life Group: EORTC Quality of Life Group Translation Procedure. EORTC, 3rd edition. March 2009. www.eortc.be (Last accessed October 10, 2009).
6. Leppert W, Majkowicz M: Ocena analgezji i objawow niepozadanych tramadolu i dihydrokodeiny o kontrolowanym uwalnianiu u chorych z bolem nowotworowym-na podstawie zmodyfikowanej skali ESAS. Wspolcz Onkol 2008; 12:246-254.
7. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life: The European Organization for Research and Treatment of Cancer QLQ-C 30: A qualityof- life instrument for use in international clinical trials in oncology. J Natl Cancer Institute 1993;85:365-376.
8. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp. 191-205.
9. Aaronson NK: Quality of Life Research in cancer clinical trials: A need for common rules and language. Oncology 1990;4:59-66.
10. Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, Lehmann KA, Cleeland CS: Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 1999;18:180-187.
11. Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F: A Brief Cancer Pain Assessment Tool in Japanese: The Utility of the Japanese Brief Pain Inventory-BPI-J. J Pain Symptom Manage 1998;16:364-373.
12. Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S: The Norwegian Brief Pain Inventory Questionnaire: Translation and validation in cancer pain patients. J Pain Symptom Manage 2002;24:517-525.
13. Kalyadina SA, Ionova TI, Ivanova MO, Uspenskaya OS, Kishtovich AV, Mendoza TR, Guo H, Novik A, Cleeland CS, Wang XS: Russian Brief Pain Inventory: Validation and application in cancer pain. J Pain Symptom Manage 2008;35: 95-102.
14. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-284.
15. Leppert W: Rola analgetykow opioidowych II stopnia drabiny analgetycznej Swiatowej Organizacji Zdrowia w leczeniu bolu nowotworowego. Onkol Pol 2006;9:145-148.